FDA — authorised 14 January 2013
- Application: NDA203634
- Marketing authorisation holder: SALIX
- Status: supplemented
FDA authorised Uceris on 14 January 2013
Yes. FDA authorised it on 14 January 2013; FDA authorised it on 7 October 2014; FDA has authorised it.
SALIX holds the US marketing authorisation.